BIOBADASAR study of cancer risk in RA patients with prev cancer treated with b/tsDMARD. No increased risk, but yet again abatacept numbers are making me slightly nervous! @rheumnow #ACR22 Abstr#0267 https://t.co/H8gYm9STT3 https://t.co/sEIS6Ljwao
Links:
Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheuma…
https://acrabstracts.org/abstract/cancer-risk-with-biologic-and-targeted-synthe…
12-11-2022